Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment ; volume:131 ; number:1 ; day:15 ; month:5 ; year:2024 ; pages:63-76 ; date:7.2024
British journal of cancer ; 131, Heft 1 (15.5.2024), 63-76, 7.2024
- Urheber
-
Masui, Hideyuki
Kawada, Kenji
Itatani, Yoshiro
Hirai, Hideyo
Nakanishi, Yuki
Kiyasu, Yoshiyuki
Hanada, Keita
Okamoto, Michio
Hirata, Wataru
Nishikawa, Yasuyo
Sugimoto, Naoko
Tamura, Takuya
Sakai, Yoshiharu
Obama, Kazutaka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-024-02710-x
- URN
-
urn:nbn:de:101:1-2409252107539.359063381333
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Masui, Hideyuki
- Kawada, Kenji
- Itatani, Yoshiro
- Hirai, Hideyo
- Nakanishi, Yuki
- Kiyasu, Yoshiyuki
- Hanada, Keita
- Okamoto, Michio
- Hirata, Wataru
- Nishikawa, Yasuyo
- Sugimoto, Naoko
- Tamura, Takuya
- Sakai, Yoshiharu
- Obama, Kazutaka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
Drugtamer‐PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy
Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”
Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy
Oxygen-supplied electrotherapy for enhanced photodynamic synergistic therapy overcomes hypoxia tumor microenvironment
Amplified intracellular Ca2+ for synergistic anti-tumor therapy of microwave ablation and chemotherapy
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
Drugtamer‐PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy
Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”
Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy
Oxygen-supplied electrotherapy for enhanced photodynamic synergistic therapy overcomes hypoxia tumor microenvironment
Amplified intracellular Ca2+ for synergistic anti-tumor therapy of microwave ablation and chemotherapy
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment
Drugtamer‐PROTAC Conjugation Strategy for Targeted PROTAC Delivery and Synergistic Antitumor Therapy
Correction to “Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine”
Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy
Oxygen-supplied electrotherapy for enhanced photodynamic synergistic therapy overcomes hypoxia tumor microenvironment